HomeBusiness NewsPromise of Eli Lilly's weight-loss drug for sleep apnea adds another reason...

Promise of Eli Lilly’s weight-loss drug for sleep apnea adds another reason to own the stock

- Advertisement -spot_imgspot_img

Eli Lilly’s Zepbound showed promise to treat obstructive sleep apnea in two late-stage trials. It’s yet another reason to stay invested in the drugmaker…

- Advertisement -spot_imgspot_img
Stay Connected
16,985FansLike
4,568FollowersFollow
Must Read
Related News

LEAVE A REPLY

Please enter your comment!
Please enter your name here